Monday, January 09, 2017 9:32:00 PM
ETAH is about as exciting as it gets on the OTCBB; the Company is quickly becoming a leader in developing and commercialization of medical devices. They are currently focusing on a needle-free injection device and pain treatment device.
[-chart]www.microcapdaily.com/wp-content/uploads/2017/01/Comfort-In-device-and-handle.jpg[/chart]
Eternity Healthcare, Inc. (ETAH) is a medical device company based in Canada that specializes in healthcare. They are successful in discovering, developing and marketing new medical devices. ETAH products are manufactured under very strict compliant with ISO 9001:2000 and NF EN ISO 13485:2003 procedures.
ETAH two leading devices are: The Lenis(R) Needle-Free Injection Device, a compact spring loaded pneumatic needle-free hypodermic injection system; and The OMNI rechargeable hand-held treatment device that delivers low-intensity laser simultaneously with a low-frequency electric pulse that provides stimulation treatments.
ETAH flagship product is the Lenis(R) needle free injection device; capable of injecting over 95% of the medicine into the body without ever having to prick the skin with a needle. The device is ideal for people with skin diseases, diabetic patients who inject insulin, kids and other people with fears of needles.
Eternity Healthcare needle free injection device is trade-marked as ‘Comfort-in’. Comfort-in’s application areas include: Diabetes, Pediatric Oncology, Multiple sclerosis, Human growth hormone, Anesthetics, Vaccine, cardiovascular diseases, and Migraine.
Several weeks ago ETAH announced the completion of its Lenis(R), Needle-Free Injection development phase. The Lenis(R) injector underwent rigorous testing, exceeding 1000 individual tests, proving not only reliable but economical. The Lenis(R) Needle-Free Injection system has four major components that each will require individual testing to satisfy regulatory approval. The main component of the system is the injector which uses a high powered spring loaded bursting mechanism.
There is a massive market for the needle free Lenis(R), injector; according to ETAH CEO Hassan Salari “We believe Lenis(R) will revolutionize medical injections as they can now be done without patient fear of needles and with a substantial reduction in cost per injection. The injection systems market is currently estimated at $9.8 Billion for 2016 and expected to grow at 15.5% until reaching $20.17 Billion in size by 2021. Unlike our competition, our design allows for delivery of larger doses, meaning Lenis(R) could be used with traditional needle and syringes used worldwide. We’re confident we have a disruptive technology.”
ETAH also owns the “OMNI TM” is a rechargeable digital hand-held pain treatment device that delivers a low intensity laser simultaneously with a low frequency electric pulse that provides stimulation treatments to effectively relieve muscle pain (analgesic effects), alleviate muscle spasm, improve microcirculation, and enhance immunity functions. The device is designed to be portable and can be used conveniently anywhere. The OMNITMis easy to operate with an easy grip and streamline appearance, suitable for in home use and by professionals.
Eternity Healthcare, Inc.
Hassan Salari
http://www.eternityhealthcare.com
STOCK INFORMATION
SYMBOL: OTCPINK: ETAH
Shares Outstanding: 66,429,868
Market Cap: $11,625,227
[-chart]www.microcapdaily.com/wp-content/uploads/2017/01/Comfort-In-device-and-handle.jpg[/chart]
Eternity Healthcare, Inc. (ETAH) is a medical device company based in Canada that specializes in healthcare. They are successful in discovering, developing and marketing new medical devices. ETAH products are manufactured under very strict compliant with ISO 9001:2000 and NF EN ISO 13485:2003 procedures.
ETAH two leading devices are: The Lenis(R) Needle-Free Injection Device, a compact spring loaded pneumatic needle-free hypodermic injection system; and The OMNI rechargeable hand-held treatment device that delivers low-intensity laser simultaneously with a low-frequency electric pulse that provides stimulation treatments.
ETAH flagship product is the Lenis(R) needle free injection device; capable of injecting over 95% of the medicine into the body without ever having to prick the skin with a needle. The device is ideal for people with skin diseases, diabetic patients who inject insulin, kids and other people with fears of needles.
Eternity Healthcare needle free injection device is trade-marked as ‘Comfort-in’. Comfort-in’s application areas include: Diabetes, Pediatric Oncology, Multiple sclerosis, Human growth hormone, Anesthetics, Vaccine, cardiovascular diseases, and Migraine.
Several weeks ago ETAH announced the completion of its Lenis(R), Needle-Free Injection development phase. The Lenis(R) injector underwent rigorous testing, exceeding 1000 individual tests, proving not only reliable but economical. The Lenis(R) Needle-Free Injection system has four major components that each will require individual testing to satisfy regulatory approval. The main component of the system is the injector which uses a high powered spring loaded bursting mechanism.
There is a massive market for the needle free Lenis(R), injector; according to ETAH CEO Hassan Salari “We believe Lenis(R) will revolutionize medical injections as they can now be done without patient fear of needles and with a substantial reduction in cost per injection. The injection systems market is currently estimated at $9.8 Billion for 2016 and expected to grow at 15.5% until reaching $20.17 Billion in size by 2021. Unlike our competition, our design allows for delivery of larger doses, meaning Lenis(R) could be used with traditional needle and syringes used worldwide. We’re confident we have a disruptive technology.”
ETAH also owns the “OMNI TM” is a rechargeable digital hand-held pain treatment device that delivers a low intensity laser simultaneously with a low frequency electric pulse that provides stimulation treatments to effectively relieve muscle pain (analgesic effects), alleviate muscle spasm, improve microcirculation, and enhance immunity functions. The device is designed to be portable and can be used conveniently anywhere. The OMNITMis easy to operate with an easy grip and streamline appearance, suitable for in home use and by professionals.
Eternity Healthcare, Inc.
Hassan Salari
http://www.eternityhealthcare.com
STOCK INFORMATION
SYMBOL: OTCPINK: ETAH
Shares Outstanding: 66,429,868
Market Cap: $11,625,227
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
